Literature DB >> 31133753

N4BP1 restricts HIV-1 and its inactivation by MALT1 promotes viral reactivation.

Daichi Yamasoba1,2,3, Kei Sato4,5,6, Takuya Ichinose1,2,3, Tomoko Imamura2, Lennart Koepke7, Simone Joas7, Elisabeth Reith7, Dominik Hotter7, Naoko Misawa4, Kotaro Akaki1,2,3, Takuya Uehata1,2, Takashi Mino1,2, Sho Miyamoto8, Takeshi Noda8, Akio Yamashita9, Daron M Standley10, Frank Kirchhoff7, Daniel Sauter7, Yoshio Koyanagi4, Osamu Takeuchi11,12.   

Abstract

RNA-modulating factors not only regulate multiple steps of cellular RNA metabolism, but also emerge as key effectors of the immune response against invading viral pathogens including human immunodeficiency virus type-1 (HIV-1). However, the cellular RNA-binding proteins involved in the establishment and maintenance of latent HIV-1 reservoirs have not been extensively studied. Here, we screened a panel of 62 cellular RNA-binding proteins and identified NEDD4-binding protein 1 (N4BP1) as a potent interferon-inducible inhibitor of HIV-1 in primary T cells and macrophages. N4BP1 harbours a prototypical PilT N terminus-like RNase domain and inhibits HIV-1 replication by interacting with and degrading viral mRNA species. Following activation of CD4+ T cells, however, N4BP1 undergoes rapid cleavage at Arg 509 by the paracaspase named mucosa-associated lymphoid tissue lymphoma translocation 1 (MALT1). Mutational analyses and knockout studies revealed that MALT1-mediated inactivation of N4BP1 facilitates the reactivation of latent HIV-1 proviruses. Taken together, our findings demonstrate that the RNase N4BP1 is an efficient restriction factor of HIV-1 and suggest that inactivation of N4BP1 by induction of MALT1 activation might facilitate elimination of latent HIV-1 reservoirs.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31133753     DOI: 10.1038/s41564-019-0460-3

Source DB:  PubMed          Journal:  Nat Microbiol        ISSN: 2058-5276            Impact factor:   17.745


  2 in total

1.  Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone.

Authors:  A Adachi; H E Gendelman; S Koenig; T Folks; R Willey; A Rabson; M A Martin
Journal:  J Virol       Date:  1986-08       Impact factor: 5.103

2.  The human immunodeficiency virus type 1 encapsidation site is a multipartite RNA element composed of functional hairpin structures.

Authors:  M S McBride; A T Panganiban
Journal:  J Virol       Date:  1996-05       Impact factor: 5.103

  2 in total
  22 in total

1.  Analysis of Protein Intermolecular Interactions with MAFFT-DASH.

Authors:  John Rozewicki; Songling Li; Kazutaka Katoh; Daron M Standley
Journal:  Methods Mol Biol       Date:  2021

2.  Caspase-8 protein cuts a brake on immune defences.

Authors:  Igor E Brodsky
Journal:  Nature       Date:  2020-11       Impact factor: 49.962

3.  Candidate host epigenetic marks predictive for HIV reservoir size, responsiveness to latency reversal, and viral rebound.

Authors:  Michael J Corley; Alina P S Pang; Thomas A Rasmussen; Martin Tolstrup; Ole S Søgaard; Lishomwa C Ndhlovu
Journal:  AIDS       Date:  2021-11-15       Impact factor: 4.177

4.  Cyclin D2 overexpression drives B1a-derived MCL-like lymphoma in mice.

Authors:  Pieter Van Vlierberghe; Steven Goossens; Tim Pieters; Sara T'Sas; Stijn Vanhee; André Almeida; Yasmine Driege; Juliette Roels; Wouter Van Loocke; Willem Daneels; Mathijs Baens; Arnaud Marchand; Maaike Van Trimpont; Filip Matthijssens; Julie Morscio; Kelly Lemeire; Béatrice Lintermans; Lindy Reunes; Patrick Chaltin; Fritz Offner; Jo Van Dorpe; Tino Hochepied; Geert Berx; Rudi Beyaert; Jens Staal
Journal:  J Exp Med       Date:  2021-08-18       Impact factor: 14.307

5.  GRK2 suppresses lymphomagenesis by inhibiting the MALT1 proto-oncoprotein.

Authors:  Jing Cheng; Linda R Klei; Nathaniel E Hubel; Ming Zhang; Rebekka Schairer; Lisa M Maurer; Hanna B Klei; Heejae Kang; Vincent J Concel; Phillip C Delekta; Eric V Dang; Michelle A Mintz; Mathijs Baens; Jason G Cyster; Narayanan Parameswaran; Margot Thome; Peter C Lucas; Linda M McAllister-Lucas
Journal:  J Clin Invest       Date:  2020-02-03       Impact factor: 14.808

6.  N4BP1 negatively regulates NF-κB by binding and inhibiting NEMO oligomerization.

Authors:  Hexin Shi; Lei Sun; Ying Wang; Aijie Liu; Xiaoming Zhan; Xiaohong Li; Miao Tang; Priscilla Anderton; Sara Hildebrand; Jiexia Quan; Sara Ludwig; Eva Marie Y Moresco; Bruce Beutler
Journal:  Nat Commun       Date:  2021-03-02       Impact factor: 14.919

7.  SERINC proteins potentiate antiviral type I IFN production and proinflammatory signaling pathways.

Authors:  Cong Zeng; Abdul A Waheed; Tianliang Li; Jingyou Yu; Yi-Min Zheng; Jacob S Yount; Haitao Wen; Eric O Freed; Shan-Lu Liu
Journal:  Sci Signal       Date:  2021-09-14       Impact factor: 9.517

8.  Porcine Reproductive and Respiratory Syndrome Virus Adapts Antiviral Innate Immunity via Manipulating MALT1.

Authors:  Han Gu; Suya Zheng; Guangwei Han; Haotian Yang; Zhuofan Deng; Zehui Liu; Fang He
Journal:  mBio       Date:  2022-04-25       Impact factor: 7.786

9.  MALT1 is a potential therapeutic target in glioblastoma and plays a crucial role in EGFR-induced NF-κB activation.

Authors:  Xuejiao Liu; Chenglong Yue; Lin Shi; Guanzheng Liu; Qiyu Cao; Qianqian Shan; Yifeng Wang; Xiangyu Chen; Huan Li; Jie Wang; Shangfeng Gao; Mingshan Niu; Rutong Yu
Journal:  J Cell Mol Med       Date:  2020-05-25       Impact factor: 5.310

10.  Integration of innate immune signalling by caspase-8 cleavage of N4BP1.

Authors:  Alexander D Gitlin; Klaus Heger; Alexander F Schubert; Rohit Reja; Donghong Yan; Victoria C Pham; Eric Suto; Juan Zhang; Youngsu C Kwon; Emily C Freund; Jing Kang; Anna Pham; Roger Caothien; Natasha Bacarro; Trent Hinkle; Min Xu; Brent S McKenzie; Benjamin Haley; Wyne P Lee; Jennie R Lill; Merone Roose-Girma; Monika Dohse; Joshua D Webster; Kim Newton; Vishva M Dixit
Journal:  Nature       Date:  2020-09-24       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.